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Abstract
Objective: Chronic non-communicable diseases such as type 2 diabetes mellitus have become global major 
health problems. In the United Republic of Tanzania, previous studies showed diabetes prevalences ranging from 
0.6% to 5.8% and of  pre-diabetes, from 9.1% to 10.6%. The pre-diabetes screening procedure described  here was 
a targeted screening to recruit eligible subjects for a subsequent dietary intervention in Moshi, Tanzania. 
Methods: The pre-diabetes screening procedure described here was used to identify subjects for a dietary 
intervention in Moshi, Tanzania. Main enrollment criteria for participants were fasting plasma glucose levels of 5.6-
6.9 mmol/L (100-125 mg/dL) on two days or on one day plus HbA1c in the range of 5.7-7.5% (39-58% mmol/mol), 
body mass index of 27-35 kg/m², and age between 30-65 years. 
Results: Through pre-screening a total of 1,256 people were examined for BMI and age; 382 people were 
further screened for markers of pre-diabetes. Following ADA and WHO-criteria, 51% (73%) had normal, 35% (13%) 
pre-diabetic, and 15% (15%) diabetic fasting plasma glucose levels. Among the individuals with hyperglycemia 
indicating diabetes mellitus, 60% were unaware of their condition. Applying ADA criteria for HbA1c to all people, 42% 
had normal, 42% had pre-diabetic, and 16% had diabetic HbA1c levels. Identified risk factors for increased fasting 
plasma glucose were age, waist circumference, body mass index, and a family history of diabetes mellitus.
Conclusion: Although the screening sample was not representative for the study area’s population and not 
diagnostic, the high rates of pre-diabetic and diabetic fasting plasma glucose levels are of public health concern. The 
low concordance  between the data for FPG and HbA1c requires further investigation, as well as the discrepancy 
between ADA and WHO definitions of impaired fasting glucose.
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Introduction
Chronic non-communicable diseases, such as type 2 diabetes 
mellitus, have become major health problems in high-income countries 
for decades but are also spreading fast in low- and middle-income 
countries [1]. Type 2 diabetes mellitus is a disease partially linked to 
overweight and obesity as well as to low physical activity [1-3]. In the 
age group of 20-79 years, the current estimate of global prevalence of 
diabetes is 8.8%, with an expected increase to 10.4% by 2040. In Sub-
Saharan Africa, the  current estimate of the regional prevalence is 3.2% 
with an expected increase to 4.2% by 2040. It is assumed that almost 
67% of diabetes patients are still undiagnosed in this region [4]. In 
Sub-Saharan Africa as well as worldwide, 90% of all cases are type 2 
diabetes mellitus [5]. The International Diabetes Federation estimated 
Tanzania’s national diabetes prevalence to be 2.3% in 2011 [6], 7.8% 
in 2013 [7], and 3.5% in 2015 [4]. Other studies showed diabetes rates 
ranging from 0.6% to 5.8% [8,9]. Prevalence of pre-diabetes, defined as 
impaired glucose tolerance (IGT), were 10.6% in 2011 [6] and 9.08% 
in 2013 [7]. Used cut-offs for IGTs are 7.8 to 11.0 mmol/L (140 to 199 
mg/dL) for 2-hour glucose levels measured during an oral glucose 
tolerance test (OGTT) with a 75 g glucose load [10,11]. Pre-diabetes 
can also be defined as impaired fasting plasma glucose (IFG) defined 
by the World Health Organization (WHO) [10] and the American 
Diabetes Association (ADA) [11] using cut-offs of 6.0 to 6.9 mmol/L 
(110 to 125 mg/dL) and 5.6 to 6.9 mmol/L (100 to 125 mg/dL), 
respectively. The use of HbA1c to classify pre-diabetes is not universally 
recommended. The ADA recommends HbA1c-cut-offs of 5.7% to 
6.4% (39 to 46 mmol/mol) for the pre-diabetic stage [11]. Pre-diabetes 
can be detected during screening at clinical visits or public screening 
activities in communities. Different screening methods may be applied 
individually or in combination, depending on the purpose and scope of 
the screening. Such methods include questionnaires, measurement of 
fasting plasma glucose FPG, random blood glucose (RBG), HbA1c, or 
conduction of an OGTT. Screening can be performed in stages, starting, 
for example, with using a questionnaire to assess risk factors, followed 
by an assessment of the glycemic status of those with elevated risk 
factor scores. The ADA recommends a screening every three years for 
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asymptomatic adults older than 45 years of age, and for younger adults 
with a BMI ≥25 kg/m² who have at least one additional risk factor such 
as low physical activity or a first-degree family member with diabetes 
[12]. However, some argue that screening for diabetes mellitus and pre-
diabetes is not justifiable [13], as it does not meet all criteria for  disease 
screening [14,15]. The pre-diabetes screening procedure described here 
was a targeted screening to identify eligible subjects for a subsequent 
dietary intervention in Moshi, Tanzania. This paper addresses the 
screening for prediabetes only. It further aims at providing insights 
into the challenges of diabetes-related health problems in East Africa. 
Methods 
The aim of the screening was to identify otherwise healthy 
pre-diabetics between 30  and 65 years of age by the following the 
criteria: Fasting plasma glucose of 5.6-6.9  mmol/L (100-125 mg/dL) on 
two days or on one day plus HbA1c in the range of 5.7- 7.5% (39-58% 
mmol/mol). To increase the chance of identifying individuals with pre 
diabetic glucose levels and without co-morbidities, a body mass index 
(BMI) between 27-35 kg/m² was chosen as an inclusion criterion for 
the current screening. Blood pressure (BP) between 90/60-160/110 
mmHg was chosen to exclude individuals with low blood pressure. 
The upper cut-off values were chosen, as a previous assessment  in the 
area detected generally high blood pressure values in the respective age 
group. The remaining inclusion criteria were waist circumference (WC) 
>80 cm  for women and >90 cm for men, absence of any diagnosed 
disease and of any regular medication, no heavy alcohol consumption, 
no pregnancy, and no breastfeeding. The study-related HbA1c upper 
limit exceeded ADA recommended cut-offs for pre-diabetes. During 
the screening, HbA1c levels were indicating notably higher glycemia 
than the corresponding FPG levels. The use of higher cut-offs in the 
HbA1c criterion was approved by the institutional review boards of 
the National Institute for Medical Research (NIMR) and Kilimanjaro 
Christian Medical College. During 2013/2014, HbA1c cartridges were 
recalibrated by HemoCue® which resulted in lower readings compared 
to old cartridges. However, a conversion factor was not provided, and 
was instead calculated by comparing old and new cartridges analyzed 
by the HemoCue® 501 analyzer (HemoCue® GmbH, Germany and 
another HbA1c point-of-care analyzer (DCA Vantage Analyzer, 
Siemens, Germany). Corrected HbA1c levels are presented in the 
current analysis. During the screening process, eligibility criteria were 
based on uncorrected HbA1c values.
Study Area
The recruitment procedure including pre-screening and screening 
for pre-diabetic participants was conducted in Moshi Urban District, 
one of the six districts of the Kilimanjaro Region in northern Tanzania. 
In 2012, the Kilimanjaro Region had a population of 1,640,087 [16]. 
Moshi Municipality, the capital of Moshi Urban District,  is divided 
into 21 wards [17] of which seven (Longuo, Rau, Karanga, Mawenzi, 
Majengo, Mji Mpya, Njoro, Pasua) were chosen as pre-screening areas 
due to their  proximity to the screening facility in Longuo or due to 
their use in previous studies. Screening took place at the Kilimanjaro 
Clinical Research Institute (KCRI), which is  closely associated with the 
Kilimanjaro Christian Medical Centre (KCMC) [18].
Recruitment Procedure
Pre-screening took place between April and October 2013 at 16 
different settings in  Moshi and addressed the following groups and 
institutions: people reached through radio announcements, doctors 
and nurses at KCMC, three Lutheran and four Roman Catholic 
churches, one convent, two banks, teachers at two primary schools, staff 
and lecturers at one university, one mosque, one police academy, one 
revenue  authority, and KCRI. In addition, individuals from the wards 
Njoro and Pasua were invited who had been identified as pre-diabetics 
in a previous study. During pre-screening, information was provided 
about the procedures, rationale and aims. Data on sex, age, BMI, 
and BP as well as contact information were collected from interested 
volunteers. In the early stages of the study, body weight was measured 
with an analogue scale and height with an elastic measurement tape 
fixed to a straight wall. In the later stages, body weight was measured 
with a digital scale (Seca 877 Germany) and portable stadiometer (Seca 
217, Germany). BMI was calculated as bodyweight in kg divided by 
the square of body height in m. While seated, each participant's BP 
was measured on the left arm using a Visomat Double Comfort blood 
pressure cuff (range: systolic 50-250 mmHg, diastolic 40-150 mmHg, 
Uebe Medical GmbH, Germany). All measurements were performed 
once. BMI and BP values were categorized according to WHO 
guidelines [19,20] and American Heart Association [21] guidelines, 
respectively. All identified participants with relevant BMI, BP and age 
were invited to the screening. To facilitate logistics and evaluation 
processes, people pre-screened at KCRI were invited to participate in 
all pre-screening and screening measurements at the same day. 
The screening and all other data collection took place at the KCRI 
between July and October 2013. Appointments were scheduled between 
7:30 and 10:30 a.m. Participants were instructed to fast overnight before 
the examination. A questionnaire-based interview was performed to 
assess socioeconomic and health related data. Data on body weight 
and height, waist and hip circumferences, BP,  FPG, and HbA1c were 
collected according to the following procedures. Body weight was 
measured using a digital scale (Seca 877, Germany). Body height was 
measured using a portable stadiometer (Seca 217, Germany) according 
to FANTA protocol [22], with participants dressed in light clothing 
and without shoes. Measurements were performed only once. Waist 
circumference and hip circumference (data not shown) were measured 
twice using a retractable  measurement band according to STEPS 
Surveillance [23]. If the difference between the two measurements was 
greater than 1 cm, a third measurement was performed.  The mean of 
the measurements was then recorded. After sitting for 5 min, blood 
pressure was measured once on the left arm using a Visomat Double 
Comfort blood  pressure cuff.
Capillary blood samples were obtained from a dry fingertip after 
disinfection using one disposable lancet for each person. FPG was 
measured using Accu-Chek Aviva® blood glucose meters (Roche 
Diagnostics, Switzerland). Glycosylated hemoglobin was measured 
using a HemoCue® 501 analyzer (HemoCue® GmbH, Germany). Both 
appliances are point-of-care devices and results were available after a 
few seconds for FPG and after five minutes for HbA1c. Participants 
with high glucose levels were advised to go to their nearest clinic for 
further medical consultation. 
All participants were reimbursed for their traveling expenses and 
given a record chart of their data, reference ranges, and a small snack. 
If requested, participants were  given counseling for nutrition and 
physical activity as part of a healthy lifestyle.
Ethics
The study protocol was approved by the Medical Research 
Coordinating Committee of the National Institute of Medical 
Research, Tanzania, the Tanzanian Food and Drug Authority, and 
the institutional review boards of the Kilimanjaro Christian Medical 
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College, and the Faculty of Medicine at Justus-Liebig-University, 
Giessen, Germany and the Regional Medical Office in Moshi. All pre-
screened and screened participants gave verbal consent to participate 
in the recruitment procedure and were informed about their right to 
withdraw at any time without any negative consequences for them.
Statistical Analysis
Data entry and analysis were performed using Microsoft Excel, 
2013 SPSS version 22, and Stata version 14. Variables are expressed 
as frequencies or as median and interquartile range. Only WC was 
consistent with a normal distribution and described by a mean and 
standard deviation. A Mann-Whitney U-test was used to identify 
differences in continuous variables between male and female 
participants. A Chi squared test was used to identify differences 
between categories in categorical variables. 
Among the pre-screening sample, Spearman's ρ was calculated 
to assess correlations. Concordance between FPG and HbA1c data 
indicating hyperglycemia was calculated using Krippendorff’s α [24]. 
Hyperglycemia was defined as FPG ≥5.6 mmol/L (≥ 100 mg/dL) or 
HbA1c ≥5.7% (≥39 mmol/216 mol). Among the screening sample, a 
non-linear model with seemingly unrelated regression (SUR) [25] was 
computed to analyze effects of age on FPG, HbA1c, and BP, as well 
as to analyze effects of WC and BMI on the dependent variables. Age 
was controlled for gender;  WC and BMI were controlled for age and 
gender. If necessary, the quadric variation  of the centered independent 
variable was used. FPG, HbA1c, and BP were log  transformed (LN) 
prior to analyses. For these particular models, participants who take 
medication regularly or were pregnant were excluded. Statistical 
significance of  different associations was assumed at a level of p<0.05 
as the individuals identified  were regarded as sample of the screened 
subpopulation.
Results 
A total of 1,256 people were pre-screened. Most people attended 
pre-screening after church services. The highest rates of eligible BMI 
and age were found among office workers and teachers, Table 1. Median 
BMI (Q25;Q75) was 27.5 kg/m² (24.1; 31.3), median age was 47.0 
years (37.0; 55.0), median systolic BP was 125.0 mmHg (114.0; 142.0), 
and median diastolic BP was 83.0 mmHg (76.0; 91.0). About 30% of 
participants had arterial hypertension, Figure 1. People with high BP 
values were directed to go to their nearest health facility for further 
medical consultation. As shown in Table 2, median BMI increased across 
age groups until the age of 60 years. The majority of the pre-screened 
participants were overweight or obese, Figure 2, likely because the 
research team stated that it was seeking participants with an increased 
body weight. Systolic BP increased across age groups, reaching the 
highest median in the oldest age group. Diastolic BP increased up to the 
age group of 50-59 years. Age was correlated with systolic BP (r = 0.371) 
and diastolic BP (r = 240 0.207). BMI was correlated with systolic BP (r 
= 0.144) and diastolic BP (r = 0.244). Systolic BP was highly correlated 
with diastolic BP (r = 0.724). All correlations were significant at the level 
of p<0.001. Systolic and diastolic BP was significantly higher in obese 
participants than in normal-weight participants (U=52793, z=4.833, 
p<0.001, r=0.178; U=45781, z=7.296, p<0.001, r=0.270, respectively). 
There was no difference between obese and overweight and between 
overweight and normal weight participants. Through pre-screening a 
total of 382 people were found eligible according to their age and BMI 
and therefore qualified for further screening. Based on ADA (WHO) 
FPG-criteria, 51% (73%) had normal, 35% (13%) had pre-diabetic, 249 
and 15% (15%) had diabetic FPG levels. Among the latter group, 60% 
were unaware of their high glucose levels. Among diagnosed diabetics 
(n=26), 50% were on prescribed medication. However, their median 
FPG and HbA1c values were higher compared to cases in which diabetes 
status was unknown Table 3. According to ADA criteria for HbA1c, 
42% had normal, 42% had pre-diabetic, and 16% had diabetic HbA1c 
levels. In the following, only the corrected HbA1c will bepresented. 
Concordance of dysglycemia between FPG and HbA1c measures 
was 68%, with a Krippendorff’s α of 0.351 indicating low reliability. 
Rates of hyperglycemia were higher according to HbA1c- than FPG-
data. Regarding concordance of HbA1c and FPG in identifying the 
glycemic status, 62% were in the  same criteria (31% both normal, 20% 
both pre-diabetic, and 11% both diabetic). Nineteen percent showed 
pre-diabetic HbA1c, but normal FPG, and 12% pre-diabetic  FPG, but 
normal HbA1c. In 7% other discordant combinations were found. The 
highest rate of concordance was observed in the diabetic category. 
Fourty-one percent of all screened participants had hypertension, 
defined by a systolic or diastolic BP meeting at least the state-I criteria, 
i.e. at least systolic BP mm Hg 140-159 or diastolic BP 90-99 mm Hg. 
Of these, 33% had previously been diagnosed with hypertension, and 
one third of them were taking medication. The remaining 67% were 
unaware of their arterial hypertension.
There was an increase in median BP and FPG values across age 
groups until 50-55 and 55-59 years, respectively, Table 4. Regarding 
undiagnosed diabetes, no clear trend was seen. Waist circumference, 
BP, and prevalence of hypertension increased from normoglycemic 
over pre-diabetic to diabetic groups, Table 5. In the diabetes  group, the 
highest percentage of family members with diabetes was found. Table 
6  shows the results of the non-linear model with seemingly unrelated 
regression (SUR). In this model, the effect of age on systolic BP was 
stronger than on FPG and HbA1c. BMI and waist circumference had 
a higher effect on FPG and HbA1c than on BP. Waist circumference 
showed a linear association with the dependent variables, whereas 
BMI showed a non-linear association. However, overall R² values were 
relatively low, with R² ranging between 0.184 and 0.248. Correlations 
of dependent variables are shown in Table 7. As expected, systolic 
B P was highly correlated with diastolic BP (0.804), and FPG with 
HbA1c (0.847). Systolic BP showed a medium, and diastolic BP a low, 
correlation with FPG and HbA1c,. 
After screening for the defined inclusion and exclusion criteria 
for the dietary intervention study, 74 people could be identified. 
Two common exclusion factors for people who met the pre-diabetes 
criterion were having high BP and taking regular medication. Overall, 
Pre-screening 
site
Pre-screened
n
People meeting BMI & 
age criteria
n               (%)
Attended
screening
n        (%)
Bank 35 21 60.0 1 4.7
Churches 595 227 38.2 131 57.7
Convent 13 6 46.2 4 66.7
Mosque 40 12 30.0 7 58.3
Primary 
schools 62 31 50.0 22 71.0
Police academy 90 42 46.7 17 40.5
Revenue 
authority 38 29 76.3 19 65.5
University 15 10 66.7 10 100
Total outside 888 378 42.5 211 55.8
Total inside 
KCRI 368 171 46.6 171 100
Overall total 1,256 549 43.7 382 69.6
Table 1: Pre-screening sites and subsequent screening attendance rates.
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the recruitment rate was 5% starting from the pre-screening phase and 
16% starting from the screening phase (based on BMI and age).
Discussion 
Screening for pre-diabetic volunteers was divided into two stages, 
a pre-screening phase and a screening phase, and was communicated 
via different channels. Due to word-of-mouth communication, 26% of 
pre-screened participants were pre-screened without prior attendance 
at information sessions, but were instead referred by already-pre-
screened people. In the pre-screening sample, rates of overweight 
and obesity were 37% and 32%, respectively. However, as people 
with increased body weight were encouraged to participate in the 
recruitment procedure, relatively high rates of overweight and obesity 
were expected. In the most recent Tanzanian  Demographic Health 
Survey (TDHS) of 2010, 35% and 24% of women in the  Kilimanjaro 
Region were overweight or obese, respectively. The TDHS did not 
report any data for men [26]. As obesity is linked to an increased risk of 
chronic non-communicable diseases and negative outcomes [27], the 
high rates of obesity, especially of classes two and three in the current 
study, are a major health threat for that area. In the current study, obese 
participants had significantly higher BP values  than normal-weight 
participants. Although sex was not recorded during the pre-screening, 
an subgroup analysis showed that women were three times more likely 
to be obese than male participants. This relation was also seen in a 
population study conducted in Mwanza District, where the obesity 
prevalence of women was 22% and that of men 7% in town settings [8]. 
In the data set of our study, a BMI in the overweight and obese ranges 
was more common among office workers and teachers than among 
people pre-screened at religious institutions. This may be linked to a 
more sedentary lifestyle due to jobs with low physical activity [28]. Vice 
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Figure 1: Classification of systolic (n = 1218) and diastolic (n = 1217) blood pressure (pre-screening).
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Figure 2: Classification of body mass index in the pre-screening sample, n=1,252.
Variable / Age 15 -19 n=9 20-29 n=96 30-39 n=237 40-49 n=316 50-59 n=322 60-69 n=124 70-79n=26 ≥0 n=10
Body mass index [kg/m²] 20.8 21.2; 27.7
24.9 
20.9; 27.7
27.8 
20.9; 27.7
29.3 
25.7; 32.5
28.6 
25.7; 31.8
27.3 
22.8; 30.5
24.9 
21.6; 28.9
23.8 
21.2; 31.0 
Systolic blood pressure 
[mmHg]
106.0 
96.5; 121.0
116.0 
107.5; 125.8
120.2 
109.0; 129.0
124.0 
114.0; 137.0
134.0 
120.0; 149.0
137.0
120.0; 152.0
143.5 
123.3; 163.0
154.0 
141.0; 162.5
Diastolic blood pressure  
[mmHg]
70.0 
64.0; 74.5
77.5 
71.0; 82.8
81.0 
74.0; 89.9
87.0 
78.0; 92.0
84.0 
79.9; 95.0
84.0 
76.0; 93.0
84.0 
78.0; 94.0
70.0 
68.0; 95.5
Table 2: Body mass index and blood pressure according to age group of the pre-screening sample n=1,140 (median & IQR).
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                                      Group
Variable
All n=382 Female n=264 Male n=118
Mean Age [years] 47.5 48 45.0 
Smoking [yes] [%] 2 0.4 6
Alcohol [yes] [%] 48 47 51
Education
  completed primary [%] 36 39 47
  completed secondary [%] 19 18 36
  college [%] 36 31 19
Reporting disease [%] 36 36 36
Regular medication [%] 22 24 19
Mean Body mass index [kg/m²] 29.9 30.7 28.3
Mean waist circumference [cm] 94.2 92.4 98.0
Diabetic family member [%] 26 29 19
Mean Fasting plasma glucose [mmol/L] 5.5 5.5 5.6
 normal fasting plasma glucose [%] 51 54 44
 pre-diabetic fasting plasma glucose [%] 35 32 42
 diabetic FPG [%] 14 14 15 
    undiagnosed diabetic FPG [%] 62 66 53
Dysglycemia [%] 49 46 56
HbA1c  [%, (mmol/mol)] 5.7 (39) 5.7 (39) 6.0 (42)
  normal 42 (70) 45 (76) 37 (58)
  pre-diabetic 42 (14) 40 (9) 46 (25)
  diabetic 16 (16) 15 (15) 17 (17)
Mean Systolic blood pressure [mmHg] 128.0 127.0 129.0 
Mean Diastolic blood pressure [mmHg] 86.0 86.0 87.0 
Overall arterial hypertension  [%] 41 41 40
Undiagnosed arterial hypertension  [%] 68 65                   71
Footnote: If not otherwise specified, data are expressed as median and interquartile range; waist circumference is presented as mean and SD;  glycemic status based 
on fasting plasma glucose (FPG) is shown using ADA and WHO (shown in parantheses) criteria; dysglycemia was defined by FPG ≥ 5.6 mmol/L (ADA) or ≥ 6.1 mmol/L 
(WHO); HbA1c is shown using ADA criteria; hypertension was defined by having at least one value in  stage I, II, or III according to American Heart Association criteria.
Table 3: Overall characteristics of screening participants (including participants with reported diseases and use of medication). 
Age group 
Variable
30-34 n=34 35-39 n=52 40-44 n=69 45-49 n=72 50-54 n=76 55-59 n=57 ≥60 n=27
Body mass index [kg/m²] 29.2 28.3; 32.2
29.2 
27.8; 32.0
30.2 
28.0; 32.1
30.8 
28.5; 32.8
29.7 
28.2; 32.0
30.2 
28.0; 31.5
30.7 
28.1; 32.6
Waist circumference [cm] 91.9 (7.9) 92.3 (7.1) 93.8 (7.7) 95.4 (7.0) 95.4 (7.0) 94.2 (6.0) 94.1 (7.2)
Fasting plasma glucose 
[mmol/L]
5.3
4.7; 5.6
5.3
4.8; 5.6
5.4
5.0; 6.1
5.6
5.1; 6.1
5.8
5.2; 6.6
5.6
5.1; 6.8
5.7
5.3; 6.2
 normal [%] 73 (91) 64 (88) 54 (75) 48 (73) 37 (61) 44 (64) 55 (68)
 pre-diabetic [%] 24 (6) 30 (6) 29 (9) 35 (10) 45 (21) 40 (20) 36 (23)
 diabetic [%] 3 6 16 17 18 16 9
 undiagnosed diab. FPG [%] 100 33 82 58 50 67 50
Dysglycemia 27 (9) 36 (12) 45 (15) 52 (27) 63 (39) 56 (26) 47 (31)
HbA1c [% (mmol/mol] 5.5 (37)5.2 (33); 5.8 (40)
5.6 (38)
5.3 (34); 5.9 (41)
5.7 (39)
5.3 (34); 6.1 (43)
5.8 (40)
5.3 (34); 6.1 (43)
5.8 (40)
5.6 (38); 6.3 (45)
5.9 (41)
5.6 (38); 6.5 (48)
5.8 (40)
5.6 (38); 6.2 (44)
Systolic blood pressure 
[mmHg]
118.5
108.5; 128.3
122.5
112; 131.8
125.0
114.5; 135.5
126.0
117.0; 143.0
131.0
120.3; 146.0
139.0
126.0; 152.5
136.0
121.8; 150.5
Diastolic blood pressure 
[mmHg]
81.0
77.0; 87.8
86.0
80.0; 91.0
84.0
78.5; 91.0
87.0
81.0; 96.0
90.0
82.0; 96.8
86.0
79.5; 96.0
89.0
78.9; 97.0
Table 4 ctd.:
Hypertension type I [%] 12 10 12 14 25 35 23
Hypertension type II [%] 0 2 4 9 9 9 9
Hypertension type III [%] 0 4 0 7 8 5 4
Overall hypertension [%] 12 16 16 30  42 49 36
Footnote: If not otherwise specified, data are expressed as median and interquartile range; waist circumference is presented as mean and SD; glycemic status based on 
fasting plasma glucose (FPG) is shown using American Diabetes Association (ADA) and World Health Organization (WHO, shown in parantheses) criteria; dysglycemia 
was defined by FPG ≥ 5.6 mmol/L (ADA) or ≥ 6.1 mmol/L (WHO); HbA1c is shown using ADA criteria; hypertension was defined by having at least one value in stage I, 
II, or III according to American Heart Association criteria.
Table 4: Anthropometric and medical data within different age groups of screened participants.
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versa, another study detected a high BMI as a predictor for a sedentary 
lifestyle [29]. Regarding increased BMI and a trend toward non-
agricultural jobs in Tanzania [30], possibilities to engage in physical 
activity outside work should be introduced. 
In the current study, BMI increased with age until 40-49 years, 
similar to results reported in the TDHS [26]. This age trend was also 
found for systolic and diastolic BP and diastolic BP peaked at the age 
group of 40-49. BP was positively correlated with BMI, stronger for 
diastolic than systolic BP. Other studies have also demonstrated age- 
and BMI-related increases in systolic and diastolic BP [31] or both as 
independent predictors for arterial hypertension [32]. Overall, 30% 
of prescreened participants were classified as hypertensive, which 
is similar to the  WHO's age-standardized estimate of 29% [1]. The 
majority was unaware of their hypertensive BP values, which was 
also seen in other settings [8] and requires attention in public health 
programs for preventing cardiovascular diseases. 
Although the screening sample was not representative for the 
population and not  diagnostic, the high rates of pre-diabetic and 
diabetic FPG values (35% and 14%, respectively) and high HbA1c 
values (42% and 16%, respectively), according to ADA criteria, are of 
                                 Group                    
Health indicator
Normal n=190 Pre-diabeticn=131 Diabetic n=52
Diagnosed 
diabetes n=20
Undiagnosed 
diabetes n=32
Treated diabetes
n=13
Age [years] 45.038.0; 53.0
49.0
42.0; 54.0
49.0
43.3; 54.0
50.0
45.0; 54.0
47.0
43.0; 54.0
53.0 
47.5; 56.0
Body mass index [kg/m²] 29.828.1; 32.3
30.2
28.1; 32.1
30.4
28.6; 31.9
30.3
28.4; 32.4
30.4
29.0; 31.8
30.2
28.0; 32.2
Diabetic family member [%] 22 22 54 80 38 92
Waist circumference [cm] 92.5 (6.9) 95.5 (7.1) 97.0 (6.3) 97.8 (6.7) 96.5 (6.0) 97.4 (7.9)
Fasting plasma glucose [mmol/L] 5.14.7; 5.3
5.9
5.7; 6.3
9.2
7.4; 13.5
12.4
8.6; 17.8
8.0
7.3; 14.1
12.2
7.5; 18.2
HbA1c [% (mmol/mol)]
5.6 (38)
5.3 (34); 
5.8 (40)
5.8 (40)
5.5 (37); 
6.1 (43)
7.7 (61)
6.6 (49); 
9.8 (84)
9.0 (75)
7.7 (61); 
10.1 (87)
6.8 (51)
6.3 (45);
 8.4 (68)
8.5 (69)
6.3 (45); 
10.1 (87)
Systolic blood pressure[mmHg] 123.5114.0; 137.3
130.0
120.0; 144.0
134.0
123.0; 155.5
133.5
122.3; 152.8
135.0
123.5; 170.5
134.0
123.8; 157.5
Table 5 ctd.: 
                  Group                  
Health indicator
Normal
n=190
Pre-diabetic
n=131
Diabetic
n=52
Diagnosed diabetes 
n=20
Undiagnosed 
diabetes 
n=32
Treated diabetes 
n=13
Diastolic blood pressure [mmHg] 84.078.0; 91.0
89.0
80.0; 96.0
90.0
84.3; 97.8
88.0
80.5; 95.3
95.5
85.1; 99.5
90.0
80.0; 98.5
Hypertension type I [%] 20 27 31 25 19 23
Hypertension type II [%] 7 12 10 10 9 15
Hypertension type III [%] 6 8 14 5 19 8
Overall hypertension [%] 33 47 55 40 47 46
Table 5: Health indicators among the different groups defined by glycemic status (according to ADA criteria)
If not otherwise specified, data are expressed as median and interquartile range; waist circumference is presented as mean and SD; hypertension was defined by having 
at least one value in stage I, II, or III according to American Heart Association criteria.
              Variable
         
Predictor
Fasting plasma glucose        HbA1c Systolic blood pressure Diastolic blood pressure Overall R²
Coefficientc p Coefficientc p Coefficientc p Coefficientc p
Agea 0.140 0.003 0.177 0.000 0.339 0.000 0.195 0.001
Age_sqa 0.142 0.001 0.098 0.012 0.019 0.765 0.064 0.298
R² 0.045 0.048 0.119 0.052 0.184
Waist 
circumferenceb 0.219 0.000 0.221 0.000 0.114 0.047 0.123 0.029
Waist CF_sqb 0.010 0.834 0.047 0.309 0.059 0.325 0.107 0.052
R² 0.093 0.086 0.134 0.078 0.248
Body mass indexb 0.142 0.003 0.130 0.005 0.008 0.893 0.026 0.682
Body mass index_
sqb 0.162 0.000 0.091 0.051 0.014 0.798 0.061 0.281
R² 0.075 0.064 0.119 0.058 0.230
aControlled for sex, bcontrolled for sex and age, cstandardized, sq = quadratic
Table 6: Results of the non-linear model using seemingly unrelated regression, n=291 for predictor age and body mass index, n=290 for predictor waist circumference.
Fasting plasma glucose HbA1c Systolic blood pressure
HbA1c 0.847
Systolic blood pressure 0.264 0.205
Diastolic blood pressure 0.197 0.150 0.804
Table 7: Correlations of dependent variables (Spearman’s rho) controlled for age and sex, all p< 0.05.
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concern. 
In a multiethnic study of pre-diabetes and diabetes mellitus 
rates were lower compared to the current setting: pre-diabetes (IFG 
according to ADA criteria) and diabetes prevalences were 10% and 
14% in South Africa, 18% and 14% in Southern Cone of Latin America, 
17% and 10% in Peru, and 4% and 19% in South Asia, respectively [33]. 
In another study, rates of pre-diabetes defined as IFG were 28% in non-
Hispanic black individuals, 27% in non-Hispanic white individuals, 
and 29% in Hispanic individuals [34].
Around 60% of the probands in Tanzania were unaware of their 
diabetic FPG levels, which was lower than the estimate of 67% in Sub-
Saharan Africa [4]. In other studies, rates of undiagnosed diabetes 
ranged from 18% to 62% [8,35,36]. The overall high prevalence 
of diabetes among the screened sample can be explained by the 
observation that a high number of diabetics came to the screening with 
the assumption they were coming to a new diabetes clinic offering free 
measurements. In the subgroup of treated diabetes patients, median 
HbA1c was 8.5% (69 mmol/mol), higher than the recommended 
target level of 7% (65 mmol/mol) for glycemic control  among 
diabetes patients [12]. In addition, HbA1c levels among people with 
diabetic FPG (treated and untreated; known and unknown) were 
high. This, together with the high levels of hypertension, indicates that 
interventions are urgent to prevent complications among people with 
diabetes mellitus in Tanzania.
According to WHO criteria, prevalence of pre-diabetes was 12%. 
As seen in other studies [36- 39], pre-diabetic prevalence rates varied 
between ADA and WHO criteria. In the current study, applying ADA 
criteria resulted in a 2.7 times higher prevalence rate than WHO 
criteria. The WHO had previously stated that lowering the threshold 
for IFG from 6.1 mmol/L to 5.6 mmol/L would result in a higher rate 
of pre-diabetes with a lack of evidence for better health outcomes [40]. 
Due to the tailored screening of people with higher BMI and age, as 
well as differences in IFG and IGT status, the pre-diabetes prevalence 
of 35% according to ADA-criteria was more than three times higher in 
this study than the reported national prevalence of 10.3% defined by 
IGT [7]. People with IFG may not necessarily have IGT, and vice versa 
[41]. In a study by Zhang et al., isolated IFG was prevalent among 27% 
of study participants, whereas 5.1% had isolated IGT and 10.3% had 
both IFG and IGT [34]. Another study by Chilelli et al., found isolated 
IFG in 27.1%, isolated IGT in 6.8%, and both in 4.6% [42]. Both applied 
ADA cut-off values for IFG, which may explain the higher rates of  pre-
diabetes based on FPG than based on glucose tolerance.
Probands with diabetic glucose levels showed the highest 
concordance between HbA1c and FPG, although the overall 
Krippendorff’s a was low (0.351). In a cross-sectional study at a 
primary care setting in Spain [43], HbA1c measurements  revealed 
a significantly lower diabetes prevalence (3.2%) compared to 2-hour 
OGTT (9.2%), but was similar to FPG (3.1%). In a population-based 
survey in a rural district of Uganda, diabetes prevalence rates were 4.8% 
according to FPG and 11.3%  according to HbA1c. Despite the low 
agreement between HbA1c and FPG, they detected a high agreement 
among negatives (normo-glycemic FPG and normal HbA1c) [37]. 
Specifying universal cut-off points for HbA1c may be difficult due to 
ethnic differences, with higher levels observed among people of African 
origin [44, 45], as well as other influencing factors [46]. However, it has 
been argued that HbA1c is a valid predictor for diabetes, including 
undiagnosed cases, but should not  be used to identify pre-
diabetes [47]. 
Regarding risk factors for increased glucose or BP values, the 
current study showed similar results as other assessments with WC and 
BMI being predictors for FPG and BP. The association between WC 
and dependent variables was linear, whereas it was non-linear for BMI. 
The current study had an upper BMI limit of 35 kg/m² whereas a higher 
limit would be needed to assess a non-linear association between BMI 
and FPG and BP. In a study in Brazil, mean BMI did not differ between 
prediabetic or normoglycemic groups, but WC was significantly 
higher among pre-diabetics than among normoglycemic participants 
[48]. In another study, obese people were two times more affected by 
dysglycemia than normal-weight people [36]. The measurement of WC 
as a low cost and noninvasive method might serve as a good screening 
tool to assess risk for dysglycemia. 
In the current study, there was no difference in BP or glycemic 
status between alcohol consumers and non-consumers. Overall, alcohol 
consumption in the study population was similar to national data [1]. 
Smoking rates were considerably lower  with 6% and 0.4% among men 
and women, compared to national data of 28% and  4%, respectively 
[1]. Thus, no association with tobacco use could be found. A study by 
Mayega found no association of abnormal glucose regulation with sex, 
age group,  hypertension, tobacco use, or harmful alcohol use [36]. 
Whether screening for diabetes will be feasible is to be discussed 
among health and policy institutions. It has been argued that screening 
for diabetes is not feasible, as it does not meet all criteria for disease 
screening [13] as defined by WHO [15]. One major criticism is that 
screening should only be done if medical treatment is available [14, 
15]. Assessments indicate that there are insufficient medical supplies 
and treatment facilities in Tanzania [49- 51]. However, as progression 
of pre-diabetes to type 2 diabetes mellitus and related complications 
might be modified with lifestyle changes [52, 53], especially increased 
physical activity, a screening of pre-diabetes or diabetes may be 
worthwhile.
Promotion of a healthy lifestyle and related activities should be 
strived for generally,  but could also be conducted with the help of 
screening, as people might be more motivated to change eating and 
physical activity habits after they know their own health status. In the 
current setting, FPG significantly dropped among some participants 
from the time point of the screening to the baseline measurement of the 
following intervention study. During the screening process, counseling 
on a healthy lifestyle was provided to participants if requested. The 
blood glucose measurement  together with counseling may already 
have led to a change in behavior and a drop in FPG. Nevertheless, in 
regard to the region's high levels of elevated BP and glucose levels, 
health promotion strategies should be established in addition to 
screening activities.
Limitations
The current study did not assess glucose tolerance. Measurement 
of glucose tolerance is not always feasible in resource-poor or work 
settings, as it is cumbersome and time consuming, especially in 
a screening setting [37, 54]. In the current screening, which had no 
diagnostic character, the measurement of FPG to define glycemic status 
was quick and easily administered by health staff. However, Yudkin 
and Montori (2014) expressed concerns about the new ADA cut-offs 
and the subsequent increase in pre-diabetes diagnoses, as well as the 
overall concept of categorizing people as pre-diabetic. They argue 
that it diverts attention from high risk  people or diabetic individuals 
who need medical attention [55]. Rates of pre-diabetes may be even 
higher when an HbA1c cut-off of 5.7 to 6.4% is applied [55]. This was 
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also the case in the current screening in which 42% of participants 
had pre-diabetic HbA1c values compared to 35% or 12% having pre 
diabetic IFG levels according to ADA or WHO criteria, respectively. 
These results were confirmed in other studies reporting higher rates 
of elevated FPG using HbA1c than FPG [37] or 2-hour OGTT [56]. 
However, some other studies showed comparable rates [43], and 
some missed cases or found lower rates when ADA’s recommended 
cut-offs for HbA1c were applied [57, 58]. Because the screening was 
tailored to include overweight and obese people, conclusions cannot 
be drawn about the overall population. Most measurements were only 
performed once, and there was no measurement of IGT to compare 
with FPG levels. The measurement of FPG was choosen as an easy 
method of assessing glycemic status in this setting. The point-of-care 
device for the measurements did not require continous access to 
electricity or extensive training of health staff. Zhao et al. demonstrated 
that the measurement of glycemic status using a capillary blood sample 
is a feasible screening method in a low-resource setting [59]. If FPG 
cannot be measured, RBG may be measured instead. Studies have 
demonstrated that a single RBG measurement of >100 mg/dL [60] or 
>125 mg/dL [61] were good predictors of diabetes.
Conclusions 
The current procedure used to recruit pre-diabetic participants for 
a dietary intervention study led to an enrollment rate of 16% among 
people with a BMI of 27- 35 kg/m² and an age of 30-65 years. The low 
concordance between FPG and HbA1c needs further investigation, as 
well as the discrepancy between ADA and WHO definitions of IFG. 
Identified risk factors for increased FPG were age, WC, BMI, and 
having a family member with diabetes. During the pre-screening and 
screening phases, high rates of obesity, undiagnosed hypertension, 
and undiagnosed diabetes were found which require an extension of 
existing health programs in scope and capacity. The visited institutions 
and companies were all receptive to health issues, and this attitude 
could be utilized for health promotion and education on prevention. 
This study was not designed as a population screening for diabetes, but 
did detect a high number of undiagnosed diabetes. Further research 
may focus on analyzing costs and benefits of screening for chronic 
non-communicable diseases in that region of Tanzania.
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